PathCare   Report issue

For profit Phase 2
Founded: Cape Town South Africa (1922)
Status: No NME R&D (1922)

Organization Overview

First Clinical Trial
2010
NCT01218217
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2010

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 2 Trials (2)

rifampin (1 trial)

sq109 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Tuberculosis (Phase 2)

Tuberculosis, Pulmonary (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 1
  • # of Trial APIs: 2